Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Promethazine hydrochloride (Phenergan® elixir) 5mg/5ml oral solution sugar free. MSN/2023/015 Tier 2 – medium impact Date of issue 15th February 2023 Promethazine hydrochloride (Phenergan® elixir) 5mg/5ml oral solution sugar free is out of stock until mid-April 2023. Promethazine hydrochloride 10mg and [...]

The post Medicine Supply Notification: Promethazine hydrochloride (Phenergan® elixir) 5mg/5ml oral solution sugar free appeared first on PSNC Website.

Community pharmacy contractors have until 11.59pm on Friday 3rd March 2023 to make their Pharmacy Quality Scheme (PQS) 2022/23 declaration through the MYS portal, as the window for claiming this payment will then close.  Contractors must have evidence to demonstrate meeting the gateway criteria and the domains that they have claimed for by the end of 31st March 2023. [...]

The post Reminder: Have you made your PQS declaration yet? appeared first on PSNC Website.

Following representations from PSNC and Dexcom International Ltd, the Department of Health of Social Care (DHSC) has confirmed that the Dexcom One Transmitter will be added to Part IXA of the March 2023 Drug Tariff. From 1st March 2023, patients will require a prescription in order to obtain a DexcomOne transmitter via their community pharmacy. Previously, patients [...]

The post Reminder: Dexcom One Transmitter to be added to March 2023 Drug Tariff appeared first on PSNC Website.

NHS England is asking community pharmacy contractors to voluntarily submit New Medicine Service (NMS) quarterly summary data to the NHS Business Services Authority (NHSBSA) for Quarter 3 (Q3) 2022/23. The mandatory requirement to submit this data has been suspended since 2020, due to the COVID-19 pandemic. NHS England want to re-start collection of the quarterly [...]

The post NMS: Voluntary quarterly data returns appeared first on PSNC Website.

By 31st March 2023, all community pharmacy contractors must have completed the 2022/23 national clinical audit on valproate, over a six-week consecutive period.  The audit aims to reduce the potential harm caused by taking valproate during pregnancy. For contractors who have not yet commenced the audit, the last day on which you can start the [...]

The post Reminder: National audit 2022/23 – valproate appeared first on PSNC Website.